Literature DB >> 9094669

Assembled coronavirus from complementation of two defective interfering RNAs.

K H Kim1, K Narayanan, S Makino.   

Abstract

In the presence of an RNA- temperature-sensitive (ts) mutant helper virus, two coronavirus mouse hepatitis virus (MHV) defective interfering (DI) RNAs complemented each other, resulting in the assembly of MHV particles; we used this ability to complement as a means to study coronavirus assembly. One of the two DI RNAs was DIssA, a naturally occurring self-replicating DI RNA encoding N protein and the gene 1 proteins that encode RNA polymerase function; DIssA supports the replication and transcription of other non-self-replicating DI RNAs. The other DI was a genetically engineered DI RNA that encoded sM and M proteins. Coinfection of these two DIs at the nonpermissive temperature for the ts helper virus resulted in replication and transcription of both DI RNAs but not in synthesis of the helper virus RNAs. MHV particles containing DI RNAs, N protein, and M protein, all of which were exclusively derived from the two DI RNAs, were released from the coinfected cells; the amount of sM protein was below the limits of detection. Analyses of DI RNAs with mutations in the two envelope protein genes demonstrated that M and sM proteins appeared to be required for assembly and release of MHV particles that contained DI RNAs and N protein, while S protein was not required for assembly and release of MHV particles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9094669      PMCID: PMC191544     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  46 in total

1.  Murine coronavirus packaging signal confers packaging to nonviral RNA.

Authors:  K Woo; M Joo; K Narayanan; K H Kim; S Makino
Journal:  J Virol       Date:  1997-01       Impact factor: 5.103

2.  Replication of coronavirus MHV-A59 in sac- cells: determination of the first site of budding of progeny virions.

Authors:  J Tooze; S Tooze; G Warren
Journal:  Eur J Cell Biol       Date:  1984-03       Impact factor: 4.492

3.  Isolation of coronavirus envelope glycoproteins and interaction with the viral nucleocapsid.

Authors:  L S Sturman; K V Holmes; J Behnke
Journal:  J Virol       Date:  1980-01       Impact factor: 5.103

4.  Coronavirus defective-interfering RNA as an expression vector: the generation of a pseudorecombinant mouse hepatitis virus expressing hemagglutinin-esterase.

Authors:  C L Liao; X Zhang; M M Lai
Journal:  Virology       Date:  1995-04-01       Impact factor: 3.616

5.  Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3.

Authors:  M M Lai; P R Brayton; R C Armen; C D Patton; C Pugh; S A Stohlman
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

6.  Viral protein synthesis in mouse hepatitis virus strain A59-infected cells: effect of tunicamycin.

Authors:  P J Rottier; M C Horzinek; B A van der Zeijst
Journal:  J Virol       Date:  1981-11       Impact factor: 5.103

7.  Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell--cell fusion.

Authors:  A R Collins; R L Knobler; H Powell; M J Buchmeier
Journal:  Virology       Date:  1982-06       Impact factor: 3.616

8.  The virus-specific intracellular RNA species of two murine coronaviruses: MHV-a59 and MHV-JHM.

Authors:  J L Leibowitz; K C Wilhelmsen; C W Bond
Journal:  Virology       Date:  1981-10-15       Impact factor: 3.616

9.  Tunicamycin resistant glycosylation of coronavirus glycoprotein: demonstration of a novel type of viral glycoprotein.

Authors:  K V Holmes; E W Doller; L S Sturman
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

10.  Sequence and topology of a model intracellular membrane protein, E1 glycoprotein, from a coronavirus.

Authors:  J Armstrong; H Niemann; S Smeekens; P Rottier; G Warren
Journal:  Nature       Date:  1984 Apr 19-25       Impact factor: 49.962

View more
  20 in total

1.  Characterization of the coronavirus M protein and nucleocapsid interaction in infected cells.

Authors:  K Narayanan; A Maeda; J Maeda; S Makino
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  Isolation and characterization of an arterivirus defective interfering RNA genome.

Authors:  R Molenkamp; B C Rozier; S Greve; W J Spaan; E J Snijder
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

3.  Severe acute respiratory syndrome coronavirus 3a protein is a viral structural protein.

Authors:  Naoto Ito; Eric C Mossel; Krishna Narayanan; Vsevolod L Popov; Cheng Huang; Taisuke Inoue; Clarence J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

4.  Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment.

Authors:  Tetsuro Ikegami; Sungyong Won; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Protein interactions during coronavirus assembly.

Authors:  V P Nguyen; B G Hogue
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Release of coronavirus E protein in membrane vesicles from virus-infected cells and E protein-expressing cells.

Authors:  J Maeda; A Maeda; S Makino
Journal:  Virology       Date:  1999-10-25       Impact factor: 3.616

7.  The function of the spike protein of mouse hepatitis virus strain A59 can be studied on virus-like particles: cleavage is not required for infectivity.

Authors:  E C Bos; W Luytjes; W J Spaan
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

8.  Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer.

Authors:  S An; C J Chen; X Yu; J L Leibowitz; S Makino
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

9.  RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells.

Authors:  S Banerjee; S An; A Zhou; R H Silverman; S Makino
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  Evolutionary transition toward defective RNAs that are infectious by complementation.

Authors:  Juan García-Arriaza; Susanna C Manrubia; Miguel Toja; Esteban Domingo; Cristina Escarmís
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.